DK165489A - 3-phenylpropanamin-derivater med selektiv inhibering af serotonin-optagelsen og fremgangsmaade til fremstilling af saadanne forbindelser - Google Patents

3-phenylpropanamin-derivater med selektiv inhibering af serotonin-optagelsen og fremgangsmaade til fremstilling af saadanne forbindelser

Info

Publication number
DK165489A
DK165489A DK165489A DK165489A DK165489A DK 165489 A DK165489 A DK 165489A DK 165489 A DK165489 A DK 165489A DK 165489 A DK165489 A DK 165489A DK 165489 A DK165489 A DK 165489A
Authority
DK
Denmark
Prior art keywords
serotonin
phenylpropanamine
derivatives
recording
compounds
Prior art date
Application number
DK165489A
Other languages
English (en)
Other versions
DK165489D0 (da
Inventor
David Wayne Robertson
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK165489D0 publication Critical patent/DK165489D0/da
Publication of DK165489A publication Critical patent/DK165489A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK165489A 1988-04-08 1989-04-06 3-phenylpropanamin-derivater med selektiv inhibering af serotonin-optagelsen og fremgangsmaade til fremstilling af saadanne forbindelser DK165489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17936888A 1988-04-08 1988-04-08

Publications (2)

Publication Number Publication Date
DK165489D0 DK165489D0 (da) 1989-04-06
DK165489A true DK165489A (da) 1989-10-09

Family

ID=22656301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK165489A DK165489A (da) 1988-04-08 1989-04-06 3-phenylpropanamin-derivater med selektiv inhibering af serotonin-optagelsen og fremgangsmaade til fremstilling af saadanne forbindelser

Country Status (19)

Country Link
EP (1) EP0336753B1 (da)
JP (1) JPH0285236A (da)
KR (1) KR890015995A (da)
CN (1) CN1036562A (da)
AT (1) ATE78029T1 (da)
AU (1) AU611794B2 (da)
CA (1) CA1337128C (da)
DE (1) DE68901994T2 (da)
DK (1) DK165489A (da)
ES (1) ES2033525T3 (da)
GR (1) GR3005662T3 (da)
HU (1) HU205344B (da)
IE (1) IE891122L (da)
IL (1) IL89854A (da)
NZ (1) NZ228636A (da)
PH (1) PH27144A (da)
PT (1) PT90212B (da)
SU (1) SU1750421A3 (da)
ZA (1) ZA892517B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK630987D0 (da) * 1987-12-01 1987-12-01 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
CA2042346A1 (en) * 1990-05-17 1991-11-18 Michael Alexander Staszak Chiral synthesis of 1-aryl-3-aminopropan-1-ols
EP0537915B1 (en) * 1991-09-27 1995-07-12 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines as norepinephrine inhibitors
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
EP0576766A1 (en) * 1992-06-29 1994-01-05 Novo Nordisk A/S Propanolamine derivatives, their preparation and use
IL110857A0 (en) * 1993-09-09 1994-11-28 Lilly Co Eli Cessation of tobacco use
US5936124A (en) * 1998-06-22 1999-08-10 Sepacor Inc. Fluoxetine process from benzoylpropionic acid
US6025517A (en) * 1998-08-03 2000-02-15 Sepracor Inc. Fluoxetine process from benzoylacetonitrile
ITMI20061987A1 (it) * 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
DE2732750A1 (de) * 1977-07-20 1979-02-08 Merck Patent Gmbh Basische thioaether und verfahren zu ihrer herstellung
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
US4147805A (en) * 1978-07-28 1979-04-03 Mead Johnson & Company Alkylthiophenoxyalkylamines and the pharmaceutical use thereof
GB2060622B (en) * 1979-09-14 1983-05-25 Wyeth John & Brother Ltd 3-aryl-3-aryloxyalkylamines
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines

Also Published As

Publication number Publication date
ES2033525T3 (es) 1993-03-16
AU3252889A (en) 1989-10-12
EP0336753A1 (en) 1989-10-11
ATE78029T1 (de) 1992-07-15
ZA892517B (en) 1990-12-28
DK165489D0 (da) 1989-04-06
AU611794B2 (en) 1991-06-20
JPH0285236A (ja) 1990-03-26
PT90212B (pt) 1994-06-30
DE68901994D1 (de) 1992-08-13
PH27144A (en) 1993-04-02
IL89854A (en) 1994-02-27
GR3005662T3 (da) 1993-06-07
NZ228636A (en) 1990-12-21
HU205344B (en) 1992-04-28
EP0336753B1 (en) 1992-07-08
PT90212A (pt) 1989-11-10
CA1337128C (en) 1995-09-26
KR890015995A (ko) 1989-11-27
DE68901994T2 (de) 1993-02-25
SU1750421A3 (ru) 1992-07-23
HUT54976A (en) 1991-04-29
IE891122L (en) 1989-10-08
CN1036562A (zh) 1989-10-25

Similar Documents

Publication Publication Date Title
NO904802D0 (no) Fremgangsmaate for fremstilling av aromatiske aminforbindelser.
ATE269290T1 (de) Benzoylderivate
DK397387D0 (da) Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK251589A (da) Fremgangsmaade til fremstilling af 1,3-dioler
DK453789D0 (da) Fremgangsmaade til paavirkning af azopigmenters triboelektriske effekt
DK165489A (da) 3-phenylpropanamin-derivater med selektiv inhibering af serotonin-optagelsen og fremgangsmaade til fremstilling af saadanne forbindelser
DK250689A (da) Fremgangsmaade til fremstilling af napthalenderivater
DK243989A (da) Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphthalener, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler indeholdende disse
NO881215L (no) Fremgangsmaate for fremstilling av alger med forbedrete biologiske virkninger.
DK656388A (da) Fremgangsmaade til iodering af en aromatisk forbindelse
DK30489D0 (da) Fremgangsmaade til fremstilling af pyranderivater
DK423284D0 (da) Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK161187A (da) 5-phenyl-5h-indenooe1,2-daapyrimidin og derivater deraf samt fremgangsmaade til fremstilling af saadanneforbindelser.
DK347989D0 (da) Fremgangsmaade til fremstilling af n15, n15- dialkylderivater af teicoplanin-forbindelser
DK356789A (da) Fremgangsmaade til hydrogenolyse af halogenerede aromatiske forbindelser
DK34888D0 (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
FI906162A0 (fi) Foerfarande foer framstaellning av 3-(n-metyl-n-alkyl)-amino-2-metoximetylenpropan-1-olderivat.
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK95588A (da) Fremgangsmaade til fremstilling af acetoacetylarylamider og -heteroarylamider af deaktiverede aromatiske forbindelser
NO905215D0 (no) Fremgangsmaate til fremstilling av 4-substituerte alkylkarbapenemforbindelser.
DK422577A (da) 3,3-diaryl-substituerede phthalider og fremgangsmaade og mellemprodukter til fremstilling af saadanne forbindelser
DK293589D0 (da) Fremgangsmaade til fremstiling af lactolderivater
DK599689D0 (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK184789A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK487989D0 (da) Fremgangsmaade til aminocarbonylering af halogenerede aromatiske forbindelser

Legal Events

Date Code Title Description
ATS Application withdrawn
PBP Patent lapsed